Invesco Ltd. Cytosorbents Corp Transaction History

Invesco Ltd.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.76 - $3.22 $24,479 - $44,786	-13,909 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.88 - $4.23 $933 - $1,370	-324 Reduced 2.28%	13,909 $44,000
Q4 2021 Feb 14, 2022	SELL	$4.05 - $8.11 $1,668 - $3,341	-412 Reduced 2.81%	14,233 $60,000
Q3 2021 Nov 15, 2021	BUY	$7.0 - $9.71 $25,207 - $34,965	3,601 Added 32.61%	14,645 $119,000
Q2 2021 Aug 17, 2021	SELL	$7.55 - $9.42 $34,224 - $42,700	-4,533 Reduced 29.1%	11,044 $83,000

Q1 2021 May 17, 2021	BUY	$8.23 - $11.48 $128,198 - $178,823	15,577 New	15,577 $136,000
Q2 2019 Aug 14, 2019	SELL	$5.92 - $7.78 $164,688 - $216,431	-27,819 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$6.82 - $8.56 $29,264 - $36,730	-4,291 Reduced 13.36%	27,819 $211,000
Q4 2018 Feb 14, 2019	BUY	$7.05 - $12.64 $226,375 - $405,870	32,110 New	32,110 $259,000

17.8M

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $39.7M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.